Pregnancy mobility boost: simple exercises show promise

NCT ID NCT07447466

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a six-week progressive resistance exercise program could improve lumbopelvic (lower back and pelvis) range of motion in women during their second trimester of pregnancy. Fifty pregnant women participated, with half doing the exercise program and half continuing usual care. The exercises focused on strengthening muscles that support the lower back and hips, aiming to ease movement and reduce pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Sep 2024

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * specified singleton intrauterine pregnancies confirmed ultrasonographically * gestational age between 14 and 28 weeks calculated from last menstrual period and corroborated by first-trimester ultrasound biometry * absence of diagnosed musculoskeletal pathology requiring medical intervention * medical clearance for moderate-intensity aerobic and resistance exercise from attending obstetricians * capacity to commit to supervised exercise sessions six days weekly for six consecutive weeks Exclusion Criteria: * encompassed high-risk pregnancy classifications including placenta previa * pregnancy-induced arterial hypertension or preeclampsia (systolic blood pressure ≥140 mmHg or diastolic ≥90 mmHg with proteinuria * gestational diabetes mellitus requiring insulin therapy * multiple gestation * incompetent cervix or cerclage placement * persistent second-trimester vaginal bleeding * premature rupture of membranes * history of preterm labor * intrauterine growth restriction below tenth percentile * contraindications to exercise per American College of Obstetricians and Gynecologists guidelines * concurrent participation in structured exercise programs exceeding 60 minutes weekly * acute lumbopelvic pain intensity exceeding six on numerical rating scale (0 to 10) necessitating pharmacological management

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lumbopelvic range of motion in second-trimester pregnancy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Joint Instability

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut Supérieur du Sport et de l'Education Physique de Ksar-Saïd

    Aryanah, Ariana Governorate, 2073, Tunisia